Lane, Earl & Cox acquired by Open Health
April 8, 2011Medical Communications Chime Communications, Lane Earl Cox, Open Health
Chime’s newly-launched healthcare comms shop Open Health has bought established UK health advertising agency Lane, Earl & Cox. It will …
AZ gets green light for thyroid cancer drug
April 7, 2011Sales and Marketing AstraZeneca, zactima
AstraZeneca’s Zactima has become the first treatment to be approved for a rare form of thyroid cancer. The orphan drug …
‘Listening exercise’ to re-shape NHS reforms
April 7, 2011Health and Social Care Bill, NHS, NHS reform
The government has paused its reforms of the NHS and launched what it calls a ‘listening exercise’ to regain support …
HRW promotes Gillian Newbold to the board
April 7, 2011Medical Communications apppointment, medical communications
Healthcare research agency HRW has promoted Gillian Newbold to its board of directors. Gillian joined the Oxfordshire, UK-based company in …
Working Life: Merck Serono’s Wolfgang Wein
April 6, 2011Research and Development, Sales and Marketing Working Life
Head of oncology at Merck Serono Wolfgang Wein explains how his field is changing, the best thing about his role …
John Gargiulo to lead Daiichi Sankyo in the US
April 6, 2011Sales and Marketing appointment, sales and marketing
Daiichi Sankyo has appointed John Gargiulo as its president and chief executive in the US. He succeeds Joseph Pieroni who …
Evil big pharma: myth or material?
April 6, 2011Research and Development, Sales and Marketing Les Rose, industry reputation
In the US the False Claims Act regulates those who attempt to defraud the government. In the last 20 years, …
Merck acquires eyecare specialist Inspire
April 6, 2011Research and Development, Sales and Marketing Inspire, Merck, eye care
Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …
Boehringer bets on Pradaxa to fill portfolio gaps
April 6, 2011Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa
Boehringer Ingelheim has identified Pradaxa as one of the cornerstones of its “new growth phase” as the manufacturer seeks to …
Kris Westelinck appointed president of Pfizer Belgium
April 5, 2011Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, researcha and development, sales and marketing
Pfizer Belgium has promoted Kris Westelinck to the role of president. Kris was previously managing director and head of Pfizer’s …
ABPI appoints new head
April 5, 2011Manufacturing and Production, Research and Development, Sales and Marketing ABPI, appointment
The ABPI has appointed former Prudential communications director Stephen Whitehead as its new head. He joins the UK pharma industry …
Digital Pharma: UK gets social media guidance
April 5, 2011Medical Communications Code of Practice, Digital Pharma blog, PMCPA, digital marketing
The UK’s Code of Practice regulator has issued guidance on social media and other digital communications tools. It is the …
J&J reorganises McNeil as recalls keep coming
April 5, 2011Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, TBA, TCA, Tylenol, manufacturing compliance, pharma manufacturing, recalls, tribromoanisole, trichloroanisole
Johnson & Johnson has announced a major reworking of its troubled McNeil Consumer Healthcare unit, just as quality problems force …
Pfizer sells drug delivery unit Capsugel for $2.38bn
April 5, 2011Manufacturing and Production Capsugel, Kohlberg Kravis Roberts & Co, Pfizer, pharmaceutical capsules
Pfizer has agreed to sell its Capsugel unit to private equity firm Kohlberg Kravis Roberts & Co. for $2.38 billion …
Government urged to slow pace of NHS reforms
April 4, 2011Sales and Marketing GP consortia, Liberating the NHS, NHS reform
The Government should slow down its health reform programme to allow GPs to grow into their new role, the think …
Interphex: manufacturing product showcase
April 4, 2011Manufacturing and Production Interphex, PTI Inspection Systems, Pall Corp
This year’s Interphex exhibition in New York featured the usual crop of new product launches from processing and packaging equipment …
China’s new GMP rules will lead to industry consolidation
April 4, 2011Manufacturing and Production China, GMP
China’s new rules on Good Manufacturing Practice is likely to drive consolidation among the country’s 5,000-plus pharmaceutical companies, according to …
New BMS drug trumps peg-interferon alpha
April 4, 2011Research and Development, Sales and Marketing BMS, EASL, hepatitis C, pegintron alfa
Bristol-Myers Squibb has been given a boost by trial results which suggest its compound for hepatitis C, PEG-Interferon lambda, is …
Doubts cast on new Cancer Drugs Fund
April 1, 2011Cancer Drugs Fund, value-based pricing
There are stark regional variations in the number of doctors using the government’s provisional Cancer Drugs Fund, according to a …
Angela Pasma to lead Chiltern’s new Netherlands office
April 1, 2011Research and Development appointment, chiltern, research and development
Contract research organisation Chiltern has expanded its European operations, opening a new office in the Netherlands. The Leiden office will …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
